ag 1879 has been researched along with imatinib mesylate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Corey, SJ; Dai, Y; Dent, P; Grant, S; Rahmani, M | 1 |
| Denis, N; Dubreuil, P; Kosmider, O; Lacout, C; Moreau-Gachelin, F; Vainchenker, W | 1 |
| Frischknecht, F; Newsome, TP; Way, M; Weisswange, I | 1 |
| Anselmi, F; Galvagni, F; Oliviero, S; Orlandini, M; Rocchigiani, M; Salameh, A | 1 |
| Auberger, P; Cassuto, JP; Colosetti, P; Gamas, P; Grosso, S; Jacquel, A; Mahon, FX; Marchetti, S; Pasquet, JM; Puissant, A | 1 |
| Caliceti, C; Fiorentini, D; Hakim, G; Hrelia, S; Prata, C; Vieceli Dalla Sega, F; Zambonin, L | 1 |
| Abraham, J; Carew, JS; Chua, YX; Druker, BJ; Giles, FJ; Glover, JM; Keller, C; Kilcoyne, A; Loriaux, MM; Michalek, JE; Nelon, LD; Ouyang, Y; Pal, R; Rubin, BP; Tyner, JW | 1 |
| Koleske, AJ; Li, S; McMahon-Pratt, D; Rhodes, EL; Wetzel, DM | 1 |
9 other study(ies) available for ag 1879 and imatinib mesylate
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.
Topics: Apoptosis; Apoptosis Inducing Factor; bcl-2-Associated X Protein; bcl-X Protein; Benzamides; Blotting, Western; Cell Line; Cell Line, Tumor; Coloring Agents; Cytochromes c; DNA-Binding Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flavoproteins; Flow Cytometry; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; K562 Cells; Membrane Potentials; Membrane Proteins; Milk Proteins; Mitochondria; Mutation; Piperazines; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; src-Family Kinases; STAT5 Transcription Factor; Tetrazolium Salts; Thiazoles; Trans-Activators; Transfection; Up-Regulation | 2004 |
Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice.
Topics: Animals; Benzamides; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Leukemia, Erythroblastic, Acute; Mice; Mice, Transgenic; Mutation; Piperazines; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Pyrazoles; Pyrimidines; Time Factors; Trans-Activators | 2005 |
Abl collaborates with Src family kinases to stimulate actin-based motility of vaccinia virus.
Topics: Actins; Animals; Benzamides; Biological Transport, Active; Cell Line; Humans; Imatinib Mesylate; Phosphorylation; Piperazines; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-yes; Pyrimidines; Signal Transduction; src-Family Kinases; Tyrosine; Vaccinia virus; Viral Structural Proteins | 2006 |
Vascular endothelial growth factor receptor-3 activity is modulated by its association with caveolin-1 on endothelial membrane.
Topics: Animals; Benzamides; Caveolae; Caveolin 1; Cell Membrane; Clone Cells; Endothelium, Vascular; Humans; Imatinib Mesylate; Lymphoid Tissue; Mice; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-abl; Proto-Oncogene Proteins pp60(c-src); Pyrimidines; Sus scrofa; Vascular Endothelial Growth Factor Receptor-3 | 2007 |
Inhibition of imatinib-mediated apoptosis by the caspase-cleaved form of the tyrosine kinase Lyn in chronic myelogenous leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Caspase 3; Caspase 9; Caspase Inhibitors; Enzyme Activation; Erythropoiesis; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Indoles; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Proteins; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Recombinant Fusion Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; src-Family Kinases; Structure-Activity Relationship; Sulfonamides | 2009 |
Effect of plasma membrane cholesterol depletion on glucose transport regulation in leukemia cells.
Topics: Benzamides; beta-Cyclodextrins; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cell Survival; Cholesterol; Cytoplasmic Vesicles; Endocytosis; Extracellular Signal-Regulated MAP Kinases; Glucose; Glucose Transporter Type 1; Humans; Imatinib Mesylate; Leukemia; Nystatin; Phloretin; Phospholipase C gamma; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Protein Transport; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; Pyrimidines; Stem Cell Factor | 2012 |
An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma.
Topics: Animals; Benzamides; Benzenesulfonates; Cell Proliferation; Drug Resistance, Neoplasm; Imatinib Mesylate; Mice; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; raf Kinases; Receptor, Platelet-Derived Growth Factor alpha; Rhabdomyosarcoma, Alveolar; Sorafenib; src-Family Kinases; Tumor Cells, Cultured | 2012 |
The Src kinases Hck, Fgr and Lyn activate Arg to facilitate IgG-mediated phagocytosis and Leishmania infection.
Topics: Aniline Compounds; Animals; Cytokines; Disease Models, Animal; Imatinib Mesylate; Immunoglobulin G; Leishmania; Leishmaniasis; Macrophages; Mice; Models, Biological; Nitriles; Parasites; Phagocytosis; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-hck; Pyrimidines; Quinolines; RAW 264.7 Cells; Signal Transduction; src-Family Kinases | 2016 |